1Gentsch JR, Woods PA, Ramachandran M, et al. Review of G and P typing results from a global collection of rotavirus strains:implication for vaccine development[J]. J Infect Dis, 1996,174(1):S30- 36.
2Perez-Schael I, Guntinas MJ, Perez M, et al. Efficacy of the rhesus rotavirus-based quadrivalent vaccine in infants and young children in Venezuela[J]. N Engl J Med, 1997,337(17):1181-1187.
3Kapikian AZ. Viral infections of the gastrointestinal tract[M].Vol 2, New York:Marcel Dekker, 1994, 409- 417.
4Kapikian AZ, Hoshino Y, Chanock RM, et al. Efficacy of a quadrivalent rhesus rotavirus -based human rotavirus vaccine aimed at preventing severe rotavirus diarrhea in infants and young children[J]. J Infect Dis, 1996,174(Suppl 1):S65-72.
5Clark HF, Offit PA, Ellis RW, et al. The development of multivalent bovine rotavirus (strain WC3) reassortant vaccine for infants[J].J Infect Dis, 1996,174(1):S73-80.
6Connor ME, Zarley CD, Hu B, et al. Virus- like particles as a rotavirus subunit vaccine[J]. J Infect Dis, 1996, 174 (Suppl 1): S88-92.
7Henmann JE, Chen SC, Fynan EF, et al. Protection against rotavirus infections by DNA vaccination[J]. J Infect Dis, 1996,174 (Suppl 1):S93-97.
8Joensuu J, Koskenniemi E, Pang XL, et al. Randomized placebocontrolled trial of rhesus-human reassortant rotavirus vaocine for prevention of severe rotavirus gastroenteritis[J]. Lancet, 1997, 350 (9086): 1205 - 1209.
9Rennels MB, Glass RI, Dennehy PH, et al. Safety and efficacy of high- dose rhesus- human reassortant rotavirus vaccines- report of the National Multicenter Trial[J]. Pediatrics, 1996, 97(1):7- 13.
10Santosham M, Moulton LH, Reid R, et al. Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations[J]. J Pediatr, 1997,131(2):632-638.
